110 related articles for article (PubMed ID: 1780240)
21. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
[TBL] [Abstract][Full Text] [Related]
22. [Dynamics of the x-ray picture of bone metastases of thyroid cancer as affected by radiotherapy].
Kiseleva ES; Zvekotkina LS; Babushkin VV
Med Radiol (Mosk); 1989 Mar; 34(3):6-10. PubMed ID: 2927278
[TBL] [Abstract][Full Text] [Related]
23. [Iodine scintigraphy of differentiated thyroid carcinoma].
Nakata K; Tsukamoto E; Ito K; Kato C; Furudate M
Rinsho Hoshasen; 1988 May; 33(5):589-90. PubMed ID: 3047462
[No Abstract] [Full Text] [Related]
24. Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma.
Giovanella L; Ceriani L; Ghelfo A; Keller F
Clin Chem Lab Med; 2005; 43(8):843-7. PubMed ID: 16201895
[TBL] [Abstract][Full Text] [Related]
25. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
[TBL] [Abstract][Full Text] [Related]
26. Value of thyroid carcinoma imaging after therapeutic doses of radioiodine.
Balachandran S; Sayle BA
Clin Nucl Med; 1981 Apr; 6(4):162-7. PubMed ID: 7214771
[TBL] [Abstract][Full Text] [Related]
27. Radioiodine I-131 therapy in the management of differentiated thyroid carcinoma: a review of 202 patients.
Chen WL; Guan SI; Huang WS
J Formos Med Assoc; 1993 Jul; 92(7):623-31. PubMed ID: 7904498
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.
Durante C; Haddy N; Baudin E; Leboulleux S; Hartl D; Travagli JP; Caillou B; Ricard M; Lumbroso JD; De Vathaire F; Schlumberger M
J Clin Endocrinol Metab; 2006 Aug; 91(8):2892-9. PubMed ID: 16684830
[TBL] [Abstract][Full Text] [Related]
29. Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose.
Joensuu H; Ahonen A
J Nucl Med; 1987 May; 28(5):910-4. PubMed ID: 3572549
[TBL] [Abstract][Full Text] [Related]
30. [Papillary thyroid carcinoma in a median ectopic thyroid associated with intra-abdominal thyroid tissue].
Hoffmann R; Bubeck B; Raue F
Dtsch Med Wochenschr; 1991 Apr; 116(17):654-8. PubMed ID: 1902162
[TBL] [Abstract][Full Text] [Related]
31. Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma.
Lindegaard MW; Paus E; Høie J; Kullman G; Stenwig AE
Acta Chir Scand; 1988 Feb; 154(2):141-5. PubMed ID: 3354295
[TBL] [Abstract][Full Text] [Related]
32. [Use of serum thyroglobulin determination in the follow-up of differentiated carcinomas of the thyroid].
Secades Ariz I; Pérez Piqueras JL; Labanda Tejedor P; Cordero Peinado J
An Med Interna; 1988 Sep; 5(9):439-43. PubMed ID: 2856622
[No Abstract] [Full Text] [Related]
33. Iodine-131 treatment of thyroid cancer: absorbed dose calculated from post-therapy scans.
Koral KF; Adler RS; Carey JE; Beierwaltes WH
J Nucl Med; 1986 Jul; 27(7):1207-11. PubMed ID: 3723194
[TBL] [Abstract][Full Text] [Related]
34. A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments.
Leger AF; Pellan M; Dagousset F; Chevalier A; Keller I; Clerc J
Br J Radiol; 2005 May; 78(929):428-32. PubMed ID: 15845937
[TBL] [Abstract][Full Text] [Related]
35. [Long-term course in differentiated thyroid gland carcinoma].
Rösler H; Birrer A; Lüscher D; Kinser J
Schweiz Med Wochenschr; 1992 Nov; 122(48):1843-57. PubMed ID: 1462145
[TBL] [Abstract][Full Text] [Related]
36. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131.
Park HM; Perkins OW; Edmondson JW; Schnute RB; Manatunga A
Thyroid; 1994; 4(1):49-54. PubMed ID: 8054861
[TBL] [Abstract][Full Text] [Related]
37. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
38. Effect of postoperative 131I treatment on thyroglobulin measurements in the follow-up of patients with thyroid cancer.
Baskin HJ
Thyroid; 1994; 4(3):239-42. PubMed ID: 7833657
[TBL] [Abstract][Full Text] [Related]
39. [Follicular carcinoma of the thyroid gland. Diagnostic and therapeutic considerations on 139 patients].
Spreafico G; Puricelli G; Gallazzi M; Colombo L; Belloni G
Radiol Med; 1983 Dec; 69(12):946-55. PubMed ID: 6678442
[TBL] [Abstract][Full Text] [Related]
40. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience.
Brown AP; Greening WP; McCready VR; Shaw HJ; Harmer CL
Br J Radiol; 1984 Apr; 57(676):323-7. PubMed ID: 6704664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]